L. Perrigo Company recalls Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802-580-46);
Perrigo recalls specific Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) due to defective delivery system. Affected products include 4-count and 10-count units with certain lot numbers. No remedy is stated in the recall notice.
Recall notice
Defective delivery system
Contact the company & request your remedy
What happened, in plain English
Perrigo is recalling specific batches of Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) because of a defective delivery system. This could lead to improper medication delivery, but the recall does not specify a remedy. Read more at govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system.
Source Summary by GovInfoNow · govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system · Updated October 7, 2026 · FDA enforcement record: FDA #D-0816-2018
Cite this page
“Perrigo Scopolamine Transdermal System Recall: Defective Delivery System.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system. Based on FDA recall #D-0816-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0816-2018%22&limit=1).
Why it’s dangerous
The defective delivery system may cause improper medication delivery, leading to ineffective treatment or potential health risks. However, the specific mechanism of failure is not detailed in the recall notice.
Who’s affected
People who have the recalled Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) with the listed lot numbers and quantities are affected. Those using the product for medical purposes are most at risk due to potential medication delivery issues.
How to tell if you have this one
Check the product label for the quantity (4-count or 10-count) and the lot number listed in the recall notice. The product is prescription-only and distributed by Perrigo.
- Brand
Perrigo- Category
Drug
What to do — step by step
Check Product Details
Identify the product quantity (4-count or 10-count) and lot number to determine if it is recalled.
Questions people ask
Is there a remedy for this recall?
The recall notice does not state any remedy.
Which products are affected?
The affected products are Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) with specific lot numbers and quantities: 4-count (NDC 45802-580-84) and 10-count (NDC 45802-580-46).
How can I tell if my product is recalled?
Check the product label for the quantity (4-count or 10-count) and the lot number listed in the recall notice.
Contact Perrigo
We’ve drafted a message you can send Perrigo to request your refund or repair — edit it as you like.
Subject: Recall D-0816-2018 — Perrigo Perrigo Hello, I own a Perrigo that is covered by recall D-0816-2018 from Perrigo. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0816-2018 (May 11, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0816-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.